Abstract
Intensive front-line protocols have improved survival in children with malignancies; however, intensive multimodal therapy of paediatric malignancies can be associated with a significant risk of serious adverse events. Common risk scores (PRISM, PRISM III, APACHE-II) fail to predict mortality in these patients. A retrospective chart analysis of 32 paediatric cancer patients admitted to the Paediatric Intensive Care Unit (PICU) at the University Hospital of Saarland between January 2001 and December 2003 for life-threatening complications was performed. The aim of this study was to assess risk factors for short-term outcome (survival vs. non-survival when leaving the PICU) and to develop a risk score to estimate outcome in these patients. Overall survival was good (25 of 32 patients). Mortality rate was significantly related to leukaemia/lymphoma ( P =0.029), to the number of organ failures ( P <0.0001), neutropenia ( P =0.001), septic shock ( P =0.025), mechanical ventilation ( P =0.01) and inotropic support ( P =0.01). Employing multiple logistic regression, the strongest predictor for poor outcome was the number of organ failures ( P <0.05). A risk score (cut-off value: >3 points for non-survival) which included the following risk factors (non-solid tumour, number of organ failures ( n >2), neutropenia, septic shock, mechanical ventilation, and inotropic medication) yielded a sensitivity of 7/7 (95% CI: 4.56–7.00), a specificity of 23/25 (95% CI: 18.49–24.75), a positive predictive value of 23/23 (95% CI: 19.80–23.00), and a negative predictive value of 7/9 (95% CI: 3.60–8.74) for the time of admission to the PICU. Conclusion:Although our risk of mortality score is of prognostic value in assessing short-term outcome in these patients, prospective validation in a larger study cohort is mandatory. Furthermore, it must be emphasised that this risk score must not be used for decision-making in an individual patient.
Similar content being viewed by others
Abbreviations
- BMT :
-
bone marrow transplantation
- GvHD :
-
graft versus host disease
- O-PRISM :
-
oncological paediatric risk of mortality score
- PICU :
-
paediatric intensive care unit
- PRISM :
-
paediatric risk of mortality score
- TISS :
-
therapeutic intervention scoring system
References
Ben Abraham R, Toren A, Ono N, Weinbroum AA, Vardi A, Barzilay Z, Paret G (2002) Predictors of outcome in the pediatric intensive care units of children with malignancies. J Pediatr Hematol Oncol 24: 23–26
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbad WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644–1655
Butt W, Barker G, Walker C, Gillis J, Kilham H, Stevens M (1988) Outcome of children with hematologic malignancy who are admitted to intensive care unit. Crit Care Med 16: 761–764
Dalton HJ, Slonim AD, Pollack MM (2003) Multicenter outcome of pediatric oncology patients requiring intensive care. Ped Hematol Oncol 20: 643–649
Diaz de Heredia C, Moreno A, Olive T, Iglesias J, Ortega JJ (1999) Role of the intensive care unit in children undergoing bone marrow transplantation with life-threatening complications. Bone Marrow Transplant 24: 163–168
Gutierrez y Lamelas R, de Camargo B (2001) Improved outcome of children with malignancy admitted to a pediatric intensive care. Crit Care Med 29: 1292
Haase R, Mathony U, Lieser U, Nagel F, Sitka U, Burdach S (2003) Oncology patients on a pediatric intensive care unit—a 7-year experience. Klin Padiatr 215: 234–240
Hallahan AR, Shaw PJ, Rowell G, O’Connell A, Schell D, Gillis J (2000) Improved outcomes of children with malignancy admitted to a pediatric intensive care unit. Crit Care Med 28: 3718–3721
Heney D, Lewis IJ, Lockwood L, Cohen AT, Bailey CC (1992) The intensive care unit in paediatric oncology. Arch Dis Child 67: 294–298
Heying R, Schneider DT, Korholz D, Stannigel H, Lemburg P, Gobel U (2001) Efficacy and outcome of intensive care in pediatric oncologic patients. Crit Care Med 29: 2276–2280
Keengwe IN, Stansfield F, Eden O, Nelhans ND, Dearlove OR, Sharples A (1999) Paediatric oncology and intensive care treatments: changing trends. Arch Dis Child 80: 553–555
Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen SM, Vincent JL, Ramsay G (2003) SCCM/ESICM/ACCP/ATS/SIS International Sepsis Conference. Crit Care Med 31: 1250–1256
Pollack MM, Patel KM, Ruttiman UE (1996) PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med 24: 743–752
Schneider DT, Lemburg P, Sprock I, Heying R, Gobel R, Nurnberger W (2000) Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children. Bone Marrow Transplant 25: 1079–1086
Sivan Y, Schwartz PH, Schonfeld T, Cohen IJ, Newth CJ (1991) Outcome of oncology patients in the pediatric intensive care unit. Intens Care Med 17: 11–15
Van Veen A, Karstens A, van der Hoek AC, Tibboel D, Haehlen K, van der Voort E (1996) The prognosis of oncologic patients in the pediatric intensive care unit. Intens Care Med 22: 237–241
Wilkinson D, Pollack MM, Ruttimann UE, Glass NL, Yeh TS (1986) Outcome of pediatric patients with multiple organ system failure. Crit Care Med 14: 271–274
Acknowledgements
We thank Karen Schneider for linguistic help with the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Meyer, S., Gottschling, S., Biran, T. et al. Assessing the risk of mortality in paediatric cancer patients admitted to the paediatric intensive care unit: a novel risk score?. Eur J Pediatr 164, 563–567 (2005). https://doi.org/10.1007/s00431-005-1695-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-005-1695-y